Solaiman Shereen bought MYGN
March 12, 2026 · Form 4 insider transaction
Solaiman Shereen bought 173,196 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
173,196
Price
$0.00
Total value
N/A
InsiderSolaiman Shereen
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after282,484
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.